WEITZMAN Jonathan : UMR7216 : Plasticity of Cellular Phenotypes

Unit : CNRS UMR7216 Epigénétique et Destin Cellulaire - Université Paris Diderot

Université Paris Diderot
CNRS UMR7216 "Epigénétique et Destin Cellulaire"
Bâtiment Lamarck, Case 7042
 35 rue Hélène Brion
75205 PARIS cedex 13

Speciality : Department BCMPP

Director of the unit : Jonathan WEITZMAN

Principal investigator :

WEITZMAN Jonathan
Email : jonathan.weitzmanSPAMFILTER@univ-paris-diderot.fr Phone number: +33 (0)6 08 24 00 09

Composition of research team :

  • WEITZMAN Jonathan (PR1,HDR)       
  • MEDJKANE Souhila (MCF, HDR)

5 Recent publications of the research team :

Cock-Rada AM*, Medjkane S*, Janski N, Yousfi N, Perichon M, Chaussepied M, Chluba J, Langsley G, and Weitzman JB. (2012) SMYD3 promotes cancer invasion by epigenetic upregulation of the metalloproteinase MMP-9. Cancer Research 72:810-20

Cock-Rada AM, and Weitzman JB. (2012) The methylation landscape of tumor metastasis. Biology Cell doi: 10.1111/boc.201200029.

Marsolier J*, Pineau S*, Medjkane S, Perichon M, Yin Q, Flemington E, Weitzman MD, Weitzman JB. OncomiR addiction is generated by a miR-155 feedback loop in Theileria-transformed leukocytes. (2013) PLoS Pathogens 9(4):e1003222. doi: 10.1371/journal.ppat.1003222

Medjkane S, Cock-Rada A, and Weitzman JB. (2012) Role of the SMYD3 histone methyltransferase in tumorigenesis: local or global effects? Cell Cycle 11:1865

Medjkane S, Perichon M, Marsolier J, Dairou J, Weitzman JB. Theileria induces oxidative stress and HIF1α activation that are essential for host leukocyte transformation (2013) Oncogene doi: 10.1038/onc.2013.134